v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:              
Net loss $ (1,794,863) $ (2,541,070) $ (5,228,919) $ (4,532,430) $ (4,335,933) $ (9,761,349)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Stock-based compensation         162,897 421,654  
Change in fair value of convertible promissory notes   787,703   787,703  
Warrant repricing         410,154  
Changes in operating assets and liabilities:              
Prepaid expenses and other current assets         368,404 821,899  
Accounts payable and other current liabilities         (5,543,149) (1,334,030)  
Operating lease right-of-use asset and liability, net         (1,193)  
Net cash used in operating activities         (8,937,627) (9,065,316)  
Cash flows from investing activities:              
Purchase of short-term investments         (4,000,000)  
Net cash used in investing activities:         (4,000,000)  
Cash flows from financing activities:              
Proceeds from issuance of convertible promissory notes         5,714,800  
Proceeds from issuance of shares of common stock and warrants         12,000,000 4,057,719  
Issuance costs         (16,181.00) (336,255)  
Net cash provided by financing activities         11,983,819 9,436,264  
Net change in cash and cash equivalents         (953,808) 370,948  
Cash and cash equivalents, beginning of period   $ 8,507,628   $ 5,786,753 8,507,628 5,786,753 $ 5,786,753
Cash and cash equivalents, end of period $ 7,553,820   $ 6,157,701   7,553,820 6,157,701 $ 8,507,628
Noncash investing and financing activities:              
Transaction costs in accounts payable and other current liabilities         5,000  
Issuance of commitment shares         109  
Conversion of Series AA and Series AAA preferred stock         $ 1,100,000